Zap70 functions to maintain stemness of mouse embryonic stem cells by negatively regulating Jak1/Stat3/c-Myc signaling.

Stem Cells
Young ChaKyung-soon Park

Abstract

Zeta-chain-associated protein kinase-70 (Zap70), a Syk family tyrosine kinase, has been reported to be present exclusively in normal T-cells, natural killer cells, and B cells, serving as a pivotal regulator of antigen-mediated receptor signaling and development. In this study, we report that Zap70 is expressed in undifferentiated mouse embryonic stem cells (mESCs) and may critically regulate self-renewal and pluripotency in mESCs. We found that Zap70 knocked-down mESCs (Zap70KD) show sustained self-renewal and defective differentiation. In addition, we present evidence that the sustained self-renewal in Zap70KD is associated with enhanced Jak/Stat3 signaling and c-Myc induction. These altered signaling appears to result from upregulated leukemia inhibitory factor receptor and downregulated src homology region 2 domain containing phosphatase 1 (SHP-1) phosphatase activity. On the basis of these results, we propose that in undifferentiated mESCs, Zap70 plays important roles in modulating the balance between self-renewal capacity and pluripotent differentiation ability as a key regulator of the Jak/Stat3/c-Myc signaling pathway.

References

Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·M NarazakiT Taga
Nov 14, 1997·The Journal of Experimental Medicine·C C DelibriasD T Fearon
Nov 6, 1998·Science·J A ThomsonJ M Jones
Jan 5, 1999·The Journal of Experimental Medicine·N KiuchiT Hirano
Aug 24, 1999·Cell·J F BrombergJ E Darnell
Jun 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·T BowmanR Jove
Apr 23, 2003·Immunity·Edina SchweighofferVictor L J Tybulewicz
Jan 17, 2004·Lancet·Jenny A OrchardDavid G Oscier
Sep 21, 2004·Oncogene·Ian Chambers, Austin Smith
Jan 28, 2005·Development·Peter CartwrightStephen Dalton
May 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Qian ZhangMariusz A Wasik
Jun 21, 2005·Journal of Cellular and Molecular Medicine·Dominic J Ambrosi, Theodore P Rasmussen
Aug 16, 2005·Stem Cells·Dalila SekkaïAnnelise Bennaceur-Griscelli
Feb 17, 2006·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·David Møbjerg KristensenJens Høiriis Nielsen
Nov 10, 2006·Proceedings of the National Academy of Sciences of the United States of America·Karen I ZellerChia-Lin Wei
Nov 23, 2006·Chemistry & Biology·Jochen SchustThorsten Berg
Jul 3, 2008·Methods : a Companion to Methods in Enzymology·Styliani MarkoulakiRudolf Jaenisch

❮ Previous
Next ❯

Citations

May 21, 2011·Stem Cells and Development·Jee-Eun JungKyung-Soon Park
Sep 27, 2014·Seminars in Cell & Developmental Biology·Veronique DubreuilSheila Harroch
Jul 12, 2016·Cell Reports·Menghui JiangYufang Shi
Apr 29, 2016·Journal of Cardiovascular Pharmacology·Xiaoying ZhangPeiqing Liu
Apr 11, 2021·Journal of Cellular and Molecular Medicine·Xiuge GuFulan Wei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.